Results 121 to 130 of about 405 (131)

ACTIVATE-KidsT: Mitapivat in Children with Pyruvate Kinase Deficiency Who Are Regularly Transfused

Blood, 2022
Rachael F. Grace, Patrick D. Tyler, Erin Larcom, Penelope A. Kosinski, Vanessa Beynon   +4 more
openaire   +1 more source

METHODS FOR TITRATING MITAPIVAT

2022
BARBIER ANN, BOWDEN CHRIS, HAWKINS PETER, IYER VARSHA, JOUVIN MARIE-HELENE   +4 more
openaire   +2 more sources

Deferasirox/Mitapivat

Reactions Weekly
openaire   +1 more source

Mitapivat - Wirksam bei Pyruvatkinase-Mangel

Österreichische Apothekerzeitung, 2022
openaire   +1 more source

METHODS FOR TITRATING MITAPIVAT FOR USE IN TREATING THALASSEMIA

2022
BARBIER ANN, BOWDEN CHRIS, HAWKINS PETER, IYER VARSHA, JOUVIN MARIE-HELENE   +4 more
openaire   +1 more source

Development and validation of stability indicating assay method for mitapivat: Identification of novel hydrolytic, photolytic, and oxidative forced degradation products employing quadrupole‐time of flight mass spectrometry

Journal of Separation Science
Swapnil Dengale
exaly  

Erste orale Therapie mit Mitapivat möglich

InFo Hämatologie + Onkologie
openaire   +1 more source

MITAPIVAT THERAPY AND MODULATORS OF CYTOCHROME P450

IYER VARSHA VENKATACHALAM, PRAKASH CHANDRA AGARWAL, YANG HUA   +2 more
openaire   +2 more sources

Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial

Lancet, The
Kittiphong Paiboonsukwong, Kanchana Chansung, Francesca Ferrara   +2 more
exaly  

ENERGIZE: Mitapivat meets primary efficacy endpoint in thalassaemia

Medicom Conference Report EHA 2024
openaire   +1 more source